Literature DB >> 32384131

Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study.

Se Hwa Kim1, Yumie Rhee2, Yoo Mee Kim1, Young Jun Won1, Junghyun Noh3, Hyemi Moon4, Juneyoung Lee4, Sin Gon Kim5.   

Abstract

OBJECTIVE: The risk of complications of nonsurgical hypoparathyroidism in Asia is unclear. We estimated the prevalence and risk of complications in patients with nonsurgical hypoparathyroidism.
METHODS: We performed a retrospective cohort study using a nationwide claims database from 2005 to 2016. Among the entire Korean population, we identified 897 patients diagnosed with nonsurgical hypoparathyroidism during 2005-2015. We selected 210 patients with nonsurgical hypoparathyroidism during 2005-2008 who had no complications at baseline and followed them to 2016. Control subjects (n = 2075) were matched using propensity scores based on age, sex, and comorbid disease with a 1:10 ratio and monitored until 2016.
RESULTS: The age-standardized prevalence of nonsurgical hypoparathyroidism was 0.2 cases per 100,000 persons in 2005. During a mean follow-up period of 9.5 years, patients with nonsurgical hypoparathyroidism had a higher risk of cardiovascular disease, especially arrhythmia (hazard ratio [HR], 2.03; 95% confidence interval [CI], 1.11-3.70) and heart failure (HR, 2.43; 95% CI, 1.22-4.83). The risk of vertebral fracture was higher in patients than in controls (HR, 2.27; 95% CI, 1.09-4.72). Patients had a significantly increased risk of renal disease (HR, 2.57; 95% CI, 1.56-4.21), seizure (HR, 5.74; 95% CI, 3.34-9.86), depression and bipolar disease (HR, 1.82; 95% CI, 1.30-2.56), and cataract (HR, 1.90; 95% CI, 1.30-2.79) compared with controls.
CONCLUSIONS: The prevalence of nonsurgical hypoparathyroidism was very low in Korea but was associated with a higher risk of incident cardiovascular disease and vertebral fracture as well as known complications including renal disease, seizure, and cataract.

Entities:  

Year:  2020        PMID: 32384131     DOI: 10.1371/journal.pone.0232842

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  7 in total

Review 1.  Fracture risk in hypoparathyroidism: a systematic review and meta-analysis.

Authors:  R Pal; S K Bhadada; S Mukherjee; M Banerjee; A Kumar
Journal:  Osteoporos Int       Date:  2021-05-22       Impact factor: 4.507

2.  Reversible heart failure in a patient with hypocalcemic cardiomyopathy.

Authors:  Mehrdad Jafari Fesharaki; Nooshin Ahmadi; Kimia Karimi Taheri
Journal:  J Geriatr Cardiol       Date:  2021-12-28       Impact factor: 3.327

3.  The Russian Registry of Chronic Hypoparathyroidism.

Authors:  Elena V Kovaleva; Anna K Eremkina; Alina R Elfimova; Julia A Krupinova; Ekaterina E Bibik; Irina S Maganeva; Anna M Gorbacheva; Ekaterina A Dobreva; Galina A Melnichenko; Natalia G Mokrysheva
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-16       Impact factor: 5.555

4.  Lower Risk of Cardiovascular Events in Adult Patients with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study.

Authors:  Olulade Ayodele; Fan Mu; Richard Berman; Elyse Swallow; Lars Rejnmark; Elvira O Gosmanova; Sanjiv Kaul
Journal:  Adv Ther       Date:  2022-06-11       Impact factor: 4.070

5.  Kidney Complications and Hospitalization in Patients With Chronic Hypoparathyroidism: A Cohort Study in Sweden.

Authors:  Oskar Swartling; Marie Evans; Tim Spelman; Wafa Kamal; Olle Kämpe; Michael Mannstadt; Ylva Trolle Lagerros; Sigridur Björnsdottir
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

6.  Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study.

Authors:  Olulade Ayodele; Lars Rejnmark; Fan Mu; Angela Lax; Richard Berman; Elyse Swallow; Elvira O Gosmanova
Journal:  Adv Ther       Date:  2022-08-26       Impact factor: 4.070

7.  Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials.

Authors:  Giulia Puliani; Valeria Hasenmajer; Ilaria Simonelli; Valentina Sada; Riccardo Pofi; Marianna Minnetti; Alessia Cozzolino; Nicola Napoli; Patrizio Pasqualetti; Daniele Gianfrilli; Andrea M Isidori
Journal:  J Bone Miner Res       Date:  2022-05-20       Impact factor: 6.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.